Tom Macleod

Leeds, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Description and therapy of palmoplantar pustular psoriasis under IL-17A or dual IL-17A/F inhibition.

Description and therapy of palmoplantar pustular psoriasis under IL-17A or dual IL-17A/F inhibition.

Journal: Journal of autoimmunity

Published: February 11, 2026

Towards a basis for vascular versus intestinal phenotype differences; East Meets West in Behcet's disease.

Towards a basis for vascular versus intestinal phenotype differences; East Meets West in Behcet's disease.

Journal: Frontiers in immunology

Published: December 01, 2025

Time to lift the moratorium on IL-23 inhibitors for axial psoriatic arthritis.

Time to lift the moratorium on IL-23 inhibitors for axial psoriatic arthritis.

Journal: The Lancet. Rheumatology

Published: August 22, 2025

Development of a PsA-like presentation under anti-IL-13 therapy with tralokinumab for atopic dermatitis.

Development of a PsA-like presentation under anti-IL-13 therapy with tralokinumab for atopic dermatitis.

Journal: Rheumatology (Oxford, England)

Published: August 20, 2025

Psoriasis patients with psoriatic arthritis demonstrate a reduced regulatory capacity for neutrophil elastase.

Psoriasis patients with psoriatic arthritis demonstrate a reduced regulatory capacity for neutrophil elastase.

Journal: Rheumatology (Oxford, England)

Published: July 11, 2025

Human spinal enthesis comparative biology of IL-17F and IL-17A reveals greater T-cell IL-17F induction and IL-23 regulation.

Human spinal enthesis comparative biology of IL-17F and IL-17A reveals greater T-cell IL-17F induction and IL-23 regulation.

Journal: Frontiers in immunology

Published: July 02, 2025

Augmentation of immunothrombosis as a key mechanism underlying JAK inhibition associated hypercoagulability in rheumatoid arthritis.

Augmentation of immunothrombosis as a key mechanism underlying JAK inhibition associated hypercoagulability in rheumatoid arthritis.

Journal: Annals of the rheumatic diseases

Published: June 01, 2025

Late-Onset Spondyloarthritis Presenting as Glucocorticoid-Resistant Polymyalgia Rheumatica: A Hitherto Underappreciated Entity in Which Tumor Necrosis Factor or Interleukin -17 Blockade May Have a Therapeutic Role.

Late-Onset Spondyloarthritis Presenting as Glucocorticoid-Resistant Polymyalgia Rheumatica: A Hitherto Underappreciated Entity in Which Tumor Necrosis Factor or Interleukin -17 Blockade May Have a Therapeutic Role.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 08, 2025

Retinoid-Associated Severe Posterior Ligamentous Predominant Soft Tissue Inflammation: A Phenotype Beyond Diffuse Idiopathic Skeletal Hyperostosis.

Retinoid-Associated Severe Posterior Ligamentous Predominant Soft Tissue Inflammation: A Phenotype Beyond Diffuse Idiopathic Skeletal Hyperostosis.

Journal: International journal of rheumatic diseases

Published: February 19, 2025

Paradoxical Activation of Entheseal Myeloid Cells by JAK1 and Tyk2 Inhibitors via Interleukin-10 Antagonism.

Paradoxical Activation of Entheseal Myeloid Cells by JAK1 and Tyk2 Inhibitors via Interleukin-10 Antagonism.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 30, 2024

How underappreciated autoinflammatory (innate immunity) mechanisms dominate disparate autoimmune disorders.

How underappreciated autoinflammatory (innate immunity) mechanisms dominate disparate autoimmune disorders.

Journal: Frontiers in immunology

Published: May 27, 2024

Takayasu arteritis: a geographically distant but immunologically proximal MHC-I-opathy.

Takayasu arteritis: a geographically distant but immunologically proximal MHC-I-opathy.

Journal: The Lancet. Rheumatology

Published: March 30, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026